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The diterpene ester promoter of mouse skin tumors, 
12-0-tetradecanoylphorbol-13-acetate (TPA), effi- 
ciently induces Epstein-Barr virus (EBV)-associated 
DNA polymerase (DNA nucleotidyltransferase) activity 
in the EBV-producing lymphoblastoid cell line, P3HR- 
1. With the use of intervent dilution chromatography 
followed by sequential DEAE-cellulose and phospho- 
cellulose column  chromatography, the virus-associated 
enzyme has been isolated and purified 300-fold. The 
partially purified EBV  DNA polymerase activity could 
be distinguished from cellular polymerases by its  acti- 
vation with salt and its degree of sensitivity  to N-ethyl- 
maleimide  and phosphonoacetic acid. The enzyme 
showed maximum activity for copying activated calf 
thymus DNA in the presence of 100 mM ammonium 
sulfate. In the absence of salt, the enzyme utilized with 
high efficiency deoxyoligomer-homopolymer tem- 
plates, but failed to copy poly(rA)-oligo(dT)lo and 
oligo(dT)lo, showing that the enzyme had properties 
distinct from DNA polymerase y, reverse transcriptase, 
and terminal deoxynucleotidyltransferase. The par- 
tially purified enzyme is strongly inhibited by acyclovir 
triphosphate and thus  has properties similar to herpes 
simplex virus DNA polymerase. 
DNA polymerase activity increases in various mammalian 
cells after infection with most herpes group viruses (1-10). 
The virus-induced enzymes  differ  from the cellular enzymes 
with respect to activity with different templates, physical 
properties, immunological  specificity, and sensitivity to chem- 
ical inhibitors. Epstein-Barr virus DNA synthesis and late 
viral antigen expression are inhibited by phosphonoacetic acid 
(11-13). The specific inhibition of viral DNA synthesis led to 
a suspicion that EBV’  may  also have its own  DNA  polymer- 
ase. Since then a number of attempts have been made to 
* These studies were supported by United States Public Health 
Service Grants CA-19014 and CA-16086 from the National Cancer 
Institute and by a grant from the Burroughs Wellcome Company. 
The costs of publication of this article were defrayed in part by the 
payment of page charges. This article must therefore be hereby 
marked “aduertisement” in accordance with 18 U.S.C. Section 1734 
solely to indicate this fact. 
+ T o  whom requests for reprints may be addressed at Cancer 
Research Center, School of Medicine, University of North Carolina, 
Chapel Hill, NC  27514. 
9 R. J. Feighny is a recipient of an individual postdoctoral fellow- 
ship award l-F32-CAo6500-01 from the National Institutes of Health. 
I The abbreviations used are: EBV, Epstein-Barr virus; TPA, 12- 
0-tetradecanoylphorbol-13-acetate; EA/VCA, early antigenhiral 
capsid antigen; PAA, phosphonoacetic acid; ACV, acyclovir[9-(2-hy- 
droxyethoxymethyl)guanine]. 
purify this enzyme 04-16), but the lack of a fully  permissive 
cell system for EBV replication has made the purification and 
characterization of the enzyme difficult. Moreover, interpre- 
tation of the results was complicated by the fact that the 
partially purified enzymes contain appreciable amounts of 
host polymerase activities (14, 16). Clearly it is essential to 
purify the virus-associated enzyme in order to study interac- 
tion with antiviral drugs. This effort is also important for an 
understanding of the regulation of replication of EBV  genomes 
found  in  virus-producing and nonproducing cells. 
Recently Zur Hausen et al. (17,  18) and Lin et al. (19) have 
shown that  the tumor-promoting agent, 12-0-tetradecanoyl- 
phorbol-13-acetate, induces 80 to 90% of P3HR-1 cells  con- 
taining latent EBV  genomes into  the viral productive cycle 
resulting in a large increase in virus production. We took 
advantage of this effect and report here that treatment of 
P3HR-1 cells with TPA results in rapid induction of virus- 
associated DNA polymerase activity. The large increase in 
the new  DNA polymerase activity enabled us to purify and 
characterize the enzyme. The properties of the purified en- 
zyme are similar to  other known herpes virus enzymes with 
some  differences (1-10). 
RESULTS‘ 
Induction of Salt-resistant DNA Polymerase Activity after 
TPA Treatment-Fig. lA shows the kinetics of induction of 
EBV-associated DNA  polymerase activity in the nuclear ex- 
tract of TPA-treated and untreated PBHR-1  cells. The nuclear 
extract of cells  grown  in the presence of TPA produced a large 
increase in DNA polymerase activity when assayed in the 
presence of 100 mM ammonium sulfate which inhibits host 
polymerases drastically (26). Induction of the enzyme  was at 
its maximum after 2 days of TPA  treatment; thereafter, the 
level of activity fell. 
With the increase in enzyme activity there was also an 
increase in the number of EBV  EA/VCA-positive  cells (results 
not presented). The maximum number of EA/VCA-positive 
cells occurs after 5 days of treatment, whereas the maximum 
level of DNA  polymerase activity is attained on the 2nd day. 
This result may  be due  to the fact that after 5 days of TPA 
treatment some  cells start  to produce virus and die. In con- 
trast, both the EBV-associated polymerase activity and per- 
centage of EA/VCA-positive  cells  in nontreated cultures re- 
’ Portions of this paper (including “Materials  and Methods,” Figs. 
2s through 6 s  and  Tables IS and 11.3) are presented in miniprint at 
the end of this paper. Miniprint is easily read with the aid of a 
standard magnifying  glass. Full size photocopies are available from 
the Journal of Biological Chemistry, 9650 Rockville Pike, Bethesda, 
Maryland 20014. Request Document No. 79M2437, cite author(s), 
and include a check or money order for $1.65 per set of photocopies. 
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FIG. 1. Kinetics of induction of EBV-associated DNA polym- 
erase  activity upon TPA treatment. P3HR-1 ( A )  and BJAB ( B )  
cells grown in suspension at lo6 cells/ml were  treated  with TPA at a 
concentration of 25 ng/ml. At the indicated  days cells were  removed, 
washed, and nuclei prepared as described under “Materials and 
Methods.” For control  experiments, cells were grown under the same 
conditions but without TPA.  The nuclear lysates were assayed for 
DNA polymerase activity in the presence of 100 mM ammonium 
sulfate. DNA polymerase activity in TPA-treated ( ) and  non- 
treated (o“-o) cells. 
mained the same after 5 days of growth. Thus  the parallel 
increase in DNA polymerase activity and EA/VCA-positive 
cells suggests that this enzyme is virus-induced. As a control 
we also treated  the EBV-negative BJAB  cell line with TPA 
under the same conditions. The  data in Fig. 1B show that 
there is no difference in the activity of DNA polymerase even 
after TPA  treatment of BJAB cells. The low level of activity 
in BJAB cells is due to  the  fact  that most of the host activities 
are drastically inhibited under the conditions of the assay. 
Since 80% of the activity was located in the nuclei, we decided 
to purify EBV-associated DNA polymerase from nuclear ex- 
tract. The detailed method of purification is presented under 
“Materials and Methods.”’ 
Effect of Salt-Almost all the herpes virus-specific  DNA 
polymerases with the exception of Marek’s disease virus can 
be distinguished from host cell polymerases by their high salt 
requirement for optimal activity (1-10). Reports on the effect 
of salt on EBV-induced DNA polymerase are inconsistent 
(14-16). As shown in Fig. 5S, the activity of the purified EBV- 
associated enzyme preparation is clearly dependent upon in- 
creased salt concentration with the maximum activity at- 
tained at 100 mM ammonium sulfate, a 5-fold increase. In 
contrast, host DNA  polymerases, a and j3, are inhibited almost 
90 to 100% by the same concentration of salt. This  character- 
istic, therefore, distinguishes the EBV-associated enzyme from 
host a and j3 polymerases. 
Reaction Requirements-Maximum activity requires all 
four deoxyribonucleoside triphosphates, DNA, Mg’+, and am- 
monium sulfate. The optimum pH  in 50 II~M Tris-HC1  buffer 
is 7 to 7.5, the reaction rates at pH 6.0 and 9.0 being 80% and 
63%, respectively, of the  rate  at  the optimum. A divalent metal 
cation is required for optimal activity, the optima for MgC12 
being 10 m; Caz+ is inhibitory to  the reaction. The apparent 
K ,  for TTP is about 1.25 PM. 
Effect ofPAA and N-Ethylmaleimide-Since all the herpes 
virus DNA polymerases have been reported to be inhibited 
specifically by PAA (27-30), we checked the effect of this 
inhibitor on the EBV DNA polymerase (Fig. 6SA). AS ex- 
pected, the EBV-associated enzyme is sensitive to PAA with 
90% of the activity abolished by 6 pg/ml of the inhibitor. 
However, the a polymerase was also sensitive, and 40% of the 
activity was abolished under the same conditions (Fig. 6SA ). 
In contrast, j3 polymerase is more resistant to  the inhibitor; 
about 70% activity remains at 50 pg/ml. 
EBV DNA polymerase is also inactivated by N-ethylma- 
leimide. At a concentration of 0.5 II~M almost 70% of the 
activity is inhibited. This is also true for a polymerase (Fig. 
6SB) ,  but j3 polymerase activity is only  slightly inhibited by 
2 mM N-ethylmaleimide. Thus  the effect of salt (Fig. 5s) and 
inhibitors (Fig. 6s )  clearly distinguishes the viral enzyme  from 
the host polymerases. 
Template Primer Requirement for EB V Polymerases- 
The use of various template primers is another way  of differ- 
entiating between various host polymerases and the viral 
polymerase (1-10). As shown in Table IIS, all the DNA 
polymerases tested effectively use activated calf thymus DNA 
as template primers, but poorly  utilize denatured and native 
calf thymus DNA as templates. The EBV-associated  polym- 
erase utilizes synthetic template primers such as poly(dA). 
oligo(dT)12-1S much more efficiently than any of the host 
polymerases. In contrast, synthetic initiated ribopolymers 
such as poly(rA)-oligo(dT)lo and deoxyoligomers such as 
oligo(dT)lo are not utilized well  by any of these polymerases. 
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FIG. 7. Effect of acyclovir (ACV) triphosphate on different 
DNA polymerase activities. EBV-associated DNA polymerase 
(M), &-DNA polymerase (A-A), and p-DNA polymerase 
(H). The method of assay has been  described under “Materials 
and Methods”  with the difference  that  indicated  amounts of acyclovir 
triphosphate  were  included  in the assay. For assay of viral-associated 
enzyme, 100 mM ammonium sulfate was included in the reaction 
mixture. 
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These results thus indicate that EBV-associated DNA  polym- 
erase is an enzyme with characteristics distinct from y polym- 
erase (26, 31), reverse transcriptase (32), and deoxyterminal 
transferase (33). 
Effect of Acyclovir Triphosphate-Studies on the mecha- 
nism of action of acyclovir, a  potent antiviral compound, have 
shown that  the compound is converted to triphosphate in the 
herpes virus-infected cell; the f i t  step of phosphorylation is 
carried out by virus-specified thymidine kinase. The triphos- 
phorylated compound thus formed inhibits viral DNA syn- 
thesis by inhibiting viral DNA polymerase (34). In Fig. 7 it is 
shown that EBV-associated  DNA polymerase is also strongly 
inhibited by the triphosphorylated form of the drug;  only 25% 
of the residual activity is detected at a concentration of 6 p ~ ,  
whereas a and /3 polymerases show 55% and 90% of the 
residual activity, respectively, at  the same concentration of 
the drug. 
DISCUSSION 
We report here a rapid and simple procedure for purification 
of EBV-associated DNA polymerase from an EBV-producing 
cell line. The purification resulted in about  a 300-fold increase 
in specific activity of the enzyme compared to crude nuclear 
extract with concomitant separation from host a, /3, and y 
polymerases. Sodium dodecyl sulfate polyacrylamide gel elec- 
trophoresis of the purified protein shows four major and 
several minor bands. Because the native enzyme does not 
enter polyacrylamide  gels in the absence of sodium dodecyl 
sulfate, it has not yet been possible to determine which 
stainable band represents active enzyme protein; neither do 
we  know the subunit composition (if any) of the protein. The 
preparation does have a low amount of deoxyribonuclease 
(possibly exonuclease) activity, but at this point we cannot 
say whether it is DNA polymerase-associated activity or any 
other independent activity. The success of this procedure is 
dependent upon two major steps. First, the use of TPA to 
obtain a sufficient quantity of virus-associated DNA  polym- 
erase activity (Fig. lA). The inability of the EBV-negative 
BJAB cell line to produce salt-resistant enzyme after TPA 
treatment (Fig. 1B) provides strong evidence that  the induced 
enzyme is virus-associated and not due  to  other biochemical 
side effects of TPA (35). Second, different DNA polymerases 
have different affinities for  DNA and can be extracted from 
the nuclei at different salt concentrations (36). This differen- 
tial affinity of the enzymes toward DNA interferes with the 
chromatographic separation of the enzymes and results in 
artifacts. 
The use of intervent dilution chromatography, a procedure 
originally devised by Kirkegaard et al. (37, 38) and subse- 
quently applied by Valenzuela et al. (39) to purify eukaryotic 
RNA polymerases, has helped to circumvent the problem. 
The procedure combines  ion  exchange and gel filtration in the 
same column (Fig. 2s). By adjusting the pH and ionic strength 
of the column it was  possible to elute the viral enzyme and a 
polymerase  in the excluded  peak (Peak I) of noninteracting 
macromolecules and before the liquid  column  volume so that 
the enzyme is eluted in the sieving range. Under the conditions 
of loading (as described under “Materials and Methods”), 
nucleic acids interact much more strongly with the ion ex- 
changer and are easily resolved from the enzyme. The en- 
zymes (or proteins) which have higher affinity for the DNA 
are retarded and eluted in the  Peak II fraction (Fig. 2s). The 
Peak 11 fraction contained p polymerase activity as detected 
by N-ethylmaleimide resistance with  some a polymerase 
cross-contamination. Although the  Peak I f  fraction had some 
poly(rA) - oligo(dT)lo activity, it was  negligible compared to 
the /3 polymerase activity. This may be due to  the fact that 
the  starting material of our enzyme preparation is nuclei and 
not the whole  cell. Thus  the intervent dilution chromatogra- 
phy step helped to  detect  both a and p polymerase activities 
in the same column. 
In  the next step of DEAE-cellulose chromatography, most 
of the virus-associated activity elutes in the flow-through 
fraction leaving contaminating a polymerase activity bound 
to the column  which can be eluted with 160 mM ammonium 
sulfate (Fig. 3s). During phosphocellulose  column chromatog- 
raphy (Fig. 4s) a small shoulder of activity occasionally ap- 
pears along with the major activity peak. We  could not detect 
any difference between the two peaks in  terms of salt stimu- 
lation and inhibitor sensitivities, but to avoid any possibility 
of cross-contamination we did all of our studies with the major 
phosphocellulose peak fraction. 
Weissbach et al. (2) and several other workers (6-9) re- 
ported that most of the herpes virus-related polymerases with 
the exception of Marek’s disease virus polymerase (5) are 
stimulated severalfold in the presence of 100 to 150 mM 
ammonium sulfate or potassium sulfate. However, several 
other reports on the  salt stimulatory property of EBV-asso- 
ciated DNA  polymerase are conflicting  (14-16). This is prob- 
ably due to  the fact that  the enzyme preparations were not 
pure and were contaminated with host enzymes which are 
sensitive to high ionic strength (26). Our unpublished data 
suggest that  the  amount of stimulation by salt is also depend- 
ent upon the quality of the activated DNA.  Allaudeen and 
Bertino (40) reported detection of an enzyme  from a patient’s 
tissue with  American Burkitt’s lymphoma which is also stim- 
ulated by 100 rn ammonium sulfate. 
A number of studies (27-31) have been published on the 
specificity of inhibition of viral  DNA synthesis by PAA. This 
effect was attributed  to specific inhibition of virus-induced 
DNA  polymerase activity. Our studies, like others (11, 16,27), 
also show that PAA inhibited not only EBV-associated DNA 
polymerase, but also host a polymerase and that the viral 
enzyme is more sensitive than a polymerase (Fig. 6SA ). Sim- 
ilarly both EBV and a polymerases are inhibited by N-ethyl- 
maleimide (Fig. SSB),  but /3 polymerase in contrast is rela- 
tively resistant to both inhibitors. These results are consistent 
with the  data obtained with intact EBV  nuclei  (41) as well as 
for other herpes virus-induced DNA polymerases (1-10) and 
probably indicate that sensitivity to PAA and N-ethylmaleim- 
ide is a general property of all the herpes virus-induced DNA 
polymerases. Our results on salt activation and PAA and N- 
ethylmaleimide inhibition are in agreement with the results 
of Bolden et al. (42) and others (14,16) but differ  significantly 
from the results of Goodman et al. (15). 
There  are several reasons to believe that  the enzyme activ- 
ity we are measuring is not  due  to mycoplasma  DNA  polym- 
erase activity (43). First, the induction of salt-stimulated 
activity in  PBHR-1  cells by TPA with respect to identically 
subcultured P3HR-1 cells in the absence of TPA makes it 
unlikely  (Fig. L4). Second, the isolation procedure is carried 
out with partially purified nuclei isolated after hypotonic 
shock. Lastly, the mycoplasma enzyme is insensitive to N -  
ethylmaleimide and PAA, and is inhibited by 100 m~ am- 
monium sulfate (43). 
The EBV-associated DNA  polymerase can efficiently  use 
activated calf thymus DNA and synthetic deoxyoligomer-ho- 
mopolymers, poly(dA) oligo(dT)12-18, as primer templates, but 
native and denatured calf thymus DNA was relatively inac- 
tive. This property resembles somewhat that of an enzyme 
found  in the herpes simplex system (2). No significant reverse 
transcriptase or deoxyterminaltransferase activities are de- 
tected in our EBV  DNA polymerase preparation. 
The different chromatographic behavior, the high  efficiency 
Purification  a d  Characterization of EB V-associated DNA Polymerase 5123 
of poly(dA) .oligo(dT) 12-18 as template primer,  and the inabil- 
ity to detect such activity in EBV-negative BJAB cells (21) 
are all consistent with the hypothesis that this virus-associ- 
ated DNA polymerase is coded  by the virus genome. These 
observations do not, however,  rule out the possibility that the 
appearance  of this new DNA polymerase  is  due to derepres- 
sion of a host cell enzyme that is not detectable in normal 
cells or to a modification  of a pre-existing host enzyme as a 
result of the presence of virus genome within the cell. The 
final  proof that this enzyme is not a modified  cellular  enzyme 
will  come from its total purification  and  characterization  and 
by detailed genetic studies. Moreover, purification of the 
enzymes wiU enable us to study in detail the sensitivity and 
interaction of the enzyme to antiviral  drugs,  in  particular  to 
[9-(2-hydroxyethoxymethyl)guanine], a new antiviral com- 
pound effective against  herpes group viruses  including  EBV 
(34) (Fig. 7).3 Work is in  progress  in this direction. 
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